Literature DB >> 2852512

A newly developed spine deformity index (SDI) to quantitate vertebral crush fractures in patients with osteoporosis.

H W Minne1, G Leidig, C Wüster, L Siromachkostov, G Baldauf, R Bickel, P Sauer, M Lojen, R Ziegler.   

Abstract

The available methods to quantitate vertebral deformity in osteoporotics are not satisfactory in comparing follow-up measurements in patients. This paper describes a newly developed 'spine deformity index' (SDI) which allows the quantitation of the extent of vertebral fractures. It is based on the observation that, in 110 normal persons, the heights of all vertebral bodies were related to each other in a predictable and constant manner. This relation was independent of the body height of the individual and was preserved despite growth acceleration during the last century. Since in all but one of our osteoporotic patients the 4th thoracic vertebra was unfractured we were able to compare the actual size of their fractured vertebrae to the calculated presumable original heights. The differences between presumable original and actual heights gave a measure of the extent of vertebral compression and allowed to define an index representing the sum of all spinal fractures in osteoporotics. The method was applied retrospectively to X-rays of 39 patients with idiopathic osteoporosis. Thirty-two of them were treated orally with 80 mg sodium fluoride, 1,000 mg calcium and 3000 IE vitamin D daily. Treatment resulted in a reduction of the progression of vertebral deformity. Seven inadequately treated patients had more pronounced progression of vertebral deformity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2852512

Source DB:  PubMed          Journal:  Bone Miner        ISSN: 0169-6009


  54 in total

1.  Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis.

Authors:  N Morabito; A Gaudio; A Lasco; C Vergara; F Tallarida; G Crisafulli; A Trifiletti; M Cincotta; M A Pizzoleo; N Frisina
Journal:  Osteoporos Int       Date:  2003-05-15       Impact factor: 4.507

Review 2.  Diagnostic value of ultrasound analysis and bone densitometry as predictors of vertebral deformity in postmenopausal women.

Authors:  S Gonnelli; C Cepollaro; D Agnusdei; R Palmieri; S Rossi; C Gennari
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

3.  Effectiveness of instant vertebral assessment to detect prevalent vertebral fracture.

Authors:  R D Chapurlat; F Duboeuf; H O Marion-Audibert; B Kalpakçioglu; B H Mitlak; P D Delmas
Journal:  Osteoporos Int       Date:  2006-06-07       Impact factor: 4.507

Review 4.  Bone imaging: traditional techniques and their interpretation.

Authors:  Holger F Boehm; Thomas M Link
Journal:  Curr Osteoporos Rep       Date:  2004-06       Impact factor: 5.096

5.  Quality of life and vertebral osteoporosis.

Authors:  J A Kanis; W H Minne; P J Meunier; R Ziegler; E Allender
Journal:  Osteoporos Int       Date:  1992-07       Impact factor: 4.507

6.  Vertebral morphometry reference data by X-ray absorptiometry (MXA) in Iranian women.

Authors:  A Salimzadeh; M Moghaddassi; G H Alishiri; M B Owlia; L Kohan
Journal:  Clin Rheumatol       Date:  2006-08-29       Impact factor: 2.980

7.  Fast kilovoltage (KV)-switching dual-energy CT virtual noncalcium technique using different reconstruction kernels for identifying acute and chronic vertebral compression fractures.

Authors:  Luyou Yan; Zeya Zhong; Hui Gao; Yewen He; Ping Li; Hongrong Shen; Shuwei Zhou; Ying Guo; Liangying Liao; Kun Zhang
Journal:  Arch Osteoporos       Date:  2021-06-03       Impact factor: 2.617

Review 8.  Assessment of prevalent and incident vertebral fractures in osteoporosis research.

Authors:  H K Genant; M Jergas
Journal:  Osteoporos Int       Date:  2003-03-12       Impact factor: 4.507

9.  Comparison of methods for the visual identification of prevalent vertebral fracture in osteoporosis.

Authors:  G Jiang; R Eastell; N A Barrington; L Ferrar
Journal:  Osteoporos Int       Date:  2004-04-08       Impact factor: 4.507

Review 10.  A risk-benefit assessment of alendronate in the treatment of involutional osteoporosis.

Authors:  J P Devogelaer
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.